argenx SE reported $36M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
AstraZeneca USD 26.01B 46M Jun/2026
Genmab DKK 4.96B 28M Jun/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
GRIFOLS EUR 7.17B 1.91B Jun/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Qiagen NV USD 1.65B 7.87M Mar/2026
UCB EUR 2.18B 634M Dec/2025